Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
NCT00936143
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Spondylitis
Interventions
DRUG:
infliximab
Sponsor
Gu Jieruo